TROP-2, Nectin-4, GPNMB, and B7-H3 Are Potentially Therapeutic Targets for Anaplastic Thyroid Carcinoma. The gene discussed is CD276; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.